We found that the growth of IL-1B overexpressing primary tumours was increased in IL1R1−/− mice compared to IL1R1fl/fl mice (Fig. 3g–h), suggesting that tumour-derived IL-1B can no longer exert its anti-tumour functions in IL1R1-deficient microenvironments. This evidence concerns the gene IL1B and neoplasm.